Search Results 351-360 of 17272 for peptide combinations
Nivolumab combination therapies in patients with ... Efficacy of first-line checkpoint inhibitors in combination ... Peptide Receptor Radionuclide Therapy for the ...
... combination with other cancer treatments for patients with relapsed ... combination with Pomalidomide/dexamethasone (Pd) in patients with relapsed ...
Mayo Clinic researcher Meng Welliver, M.D., Ph.D., studies biomarker-guided, combination treatments that personalize radiation therapy for rare and ...
The purpose of this study is to evaluate SV-BR-1-GM in metastatic or locally recurrent breast cancer patients, in combination with the PD-1 inhibitor ...
The purpose of this study is to evaluate whether encorafenib plus cetuximab (EC), alone or in combination with chemotherapy, can improve clinical outcomes ...
... combination with capecitabine in adult patients with gastrin releasing peptide receptor positive, estrogen receptor-positive, human epidermal growth ...
This resource-platform will be named Project BTTRFLY (Benevolent Tumor Tissue Repository Fighting for the Legacy of our Young). Avelumab In Combination Regimens ...
Proton beam radiation therapy is one of the treatments for men with prostate cancer who have localized disease. The benefit of the combination with androgen ...
... combination with immune checkpoint inhibitors in pancreatic adenocarcinoma ... combination with immune checkpoint inhibitors (ICIs) in preclinical settings.
The purpose of this study is to evaluate the safety and tolerability of the combination of DS-8201a in combination with olaparib, and to determine the ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!